PARALLEL SESSION 2B: Global Infections and Inflammatory Diseases of the CNS
Tracks
SKALKOTAS HALL
| Wednesday, September 18, 2019 |
| 4:30 PM - 6:15 PM |
| SKALKOTAS HALL |
Overview
Joint session with ICNA
Speaker
Dr. Richard Idro
Mulago Hospital, Makerere University College of Health Sciences
Encephalitis
4:30 PM - 4:55 PM
Dr. Lauren Krupp
Pediatric MS Center, NYU Langone
OC026 | Fingolimod treatment improved quality of life in paediatric patients with Multiple Sclerosis: PARADIGMS study
Ms. Aliénor De Chalus
Assistance Publique-hôpitaux De Paris, Hôpitaux Universitaires Paris Sud- Pediatric Neurology Department
OC027 | The 2017 McDonald Diagnostic criteria: validation in the French Paediatric Onset Multiple Sclerosis cohort
Dr. Omar Abdel-Mannan
Great Ormond Street Hospital for Children
OC028 | Improved performance of the 2017 McDonald criteria for diagnosis of Multiple Sclerosis in children in a real-life cohort
Dr. Omar Abdel-Mannan
Great Ormond Street Hospital for Children
OC029 | Use of disease-modifying therapies in paediatric relapsing remitting Multiple Sclerosis in the UK: a multi-centre retrospective study
Ms. Aphra Luchesa Smith
University College London
OC030 | Progress in the management of paediatric-onset Multiple Sclerosis over the last decade
.
Discussion
6:10 PM - 6:15 PMChair
Antigone Papavasiliou
IASO Children’s Hospital, Athens, Greece
Michèl A.A.P. Willemsen
Radboud University Medical Centre
